Postmarketing surveillance study of a non-chlorofluorocarbon inhaler according to the safety assessment of marketed medicines guidelines

British Medical Journal

Volumn 317, Issue 7163, 1998, Pages 926-930

  Ayres, J G ^a   Frost, C D ^a   Holmes, W F ^a   Williams, D R R ^a   Ward, S M ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROFLUOROCARBON; FLUORINATED HYDROCARBON; PROPELLANT; SALBUTAMOL;

ADULT; AGED; ARTICLE; BRONCHOSPASM; DRUG SAFETY; FEMALE; FOLLOW UP; GENERAL PRACTICE; HOSPITAL ADMISSION; HUMAN; INFECTION; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; OBSTRUCTIVE AIRWAY DISEASE; POSTMARKETING SURVEILLANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; UPPER RESPIRATORY TRACT INFECTION;

EID: 0032480585     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.317.7163.926     Document Type: Article

References (9)